SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-22-037574
Filing Date
2022-07-06
Accepted
2022-07-06 14:43:20
Documents
6

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea162509-424b3_inmedpharma.htm 424B3 275910
2 GRAPHIC image_001.jpg GRAPHIC 5649
3 GRAPHIC image_002.jpg GRAPHIC 16390
4 GRAPHIC image_003.jpg GRAPHIC 44478
5 GRAPHIC image_004.jpg GRAPHIC 26997
6 GRAPHIC image_005.jpg GRAPHIC 6322
  Complete submission text file 0001213900-22-037574.txt   415059
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-265731 | Film No.: 221068354
SIC: 2834 Pharmaceutical Preparations